Significance of an abnormal response during pituitary desensitization in an in vitro fertilization and embryo transfer program

Journal of Assisted Reproduction and Genetics

Volumn 13, Issue 5, 1996, Pages 374-380

  Goswami, S K ^a   Chakravarty, B N ^a   Kabir, Syed N ^b  

^a Institute of Reproductive Medicine   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

aberrant response to GnRH a; gonadotropin releasing hormone agonist (GnRH a) receptor down regulation; in vitro fertilization

Indexed keywords

BUSERELIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; EMBRYO TRANSFER; ESTROGEN BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HORMONE RESPONSE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OOCYTE CLEAVAGE; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FORECASTING; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; OOCYTES; OVARY; PITUITARY GLAND; PREGNANCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0029982391     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02066167     Document Type: Article

References (25)

1. Insler V, Lunenfeld B: Human gonadotropins. In Infertility: Male and Female, V Insler, B Lunenfeld (eds). New York. Churchill Livingstone, 1993, pp 387-417
2. Fleming R, Coutts JRT: Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 1986;45:226-230
3. Eibschitz I, Belaisch-Allart JC, Frydman R: In vitro fertilization management and results in stimulated cycles with spontaneous luteinizing hormone discharge. Fertil Steril 1986;45:231-236
4. Schmutzler RK, Reichert C, Diedrich K, Wildt I, Diedrich C, Al Hasani S, et al.: Combined GnRH-agonist/gonadotropin stimulation for in vitro fertilization. Hum Reprod 1988;3 (Suppl 4):29-33
5. Droesch K, Muasher SH, Brzyski RG, Jones GS, Simonetti S, Liu H-C, Rosenwaks Z: Value of suppression with a gonadotropin releasing hormone agonist prior to gonadotropin stimulation for IVF. Fertil Steril 1989;51:292-297
6. San Roman GA, Surrey ES, Judd H L, Kerin JF: A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin releasing hormone agonist for in vitro fertilization. Fertil Steril 1992;58:744-749
7. Ron-El R, Herman A, Golan A, Soffer Y, Nachum H, Caspi E: Ultrashort gonadotropin releasing hormone agonsist (GnRH-a) protocol in comparison with the long-acting GnRH-a protocol and menotropin alone. Fertil Steril 1992;58:1164-1168
8. Seifer DB, Thornton KL, DeCherney AH, Lavy G: Early pituitary desensitization and ovarian suppression with leuprolide acetate is associated with in vitro fertilization-embryo transfer success. Fertil Steril 1991;56:500-504
9. Penzias AS, Lee G, Seifer DB, Shamma FN, DeCherney A H, Reindollar RH, Jones EE: Aberrant estradiol flare despite gonadotropin-releasing hormone-agonist-induced suppression is associated with impaired implantation. Fertil Steril 1994;61:558-560
10. World Health Organization: WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction, 2nd ed. Cambridge, Cambridge University Press, 1987, Vol 3, p 27
11. Fluker MR, Monroe SE, Marshall LA, Jaffe RB: Contrasting effects of a gonadotropin-releasing hormone agonist and antagonist on the secretion of free alpha subunit. Fertil Steril 1994;61:573-575
12. Meldrum DR, Tsao Z, Monroe SE, Braunstein GD, Sladek J, Lu JKH, Vale W, Rivier J, Judd HL, Chang RJ: Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women, J Clin Endocrinol Metab 1984;58:755-757
13. Lincoln SR, Long CA, Whitworth NS, Sopelak VM, Cowan BD: Elevated luteinizing hormone on the day of human chorionic gonadotropin administration does not reduce cycle fecundity in a low-dose flare-up in vitro fertilization protocol. Fertil Steril 1995;63:563-565
14. Ben-Rafael Z, Menashe Y, Mimon R, Lipitz S, Bider D, Zolti M, et al.: Limitations in the use of combined gonadotropin releasing hormone analog and human menopausal gonadotropin for din vitro fertilization. In Advances in Assisted Reproductive Technologies, S Mashiach, Z Ben-Rafael, N Laufer, J Schenker (eds). New York, Plenum Press, 1990, pp 17-29
15. Dahl KD, Bicsak TA, Hsueh AJ: Naturally occurring anti-hormones: Secretion of FSH antagonists by women treated with a GnRH-analog. Science 1988;239:72-74
16. Scott RT, Neal GS, Illions EH, Hayslip CA, Hofmann GE: The duration of leuprolide acetate administration piror to ovulation induction does not impact ovarian responsiveness to exogenous gonadotropins. Fertil Steril 1993;60:247-253
17. Chang SY, Lee CL, Wang ML, Hu ML, Lai YM, Chang MY, Soong YK: No detrimental effects in delaying initiation of gonadotropin administration after pituitary desensitization with gonadotropin-releasing hormone agonist. Fertil Steril 1993;59:183-186
18. Insler V, Lunenfeld E, Potashnik G, Levy J: Ovarian stimulation concomitant with pituitary-ovarian axis suppression by different GnRH-agonists. Int J Fertil 1991;36:121-127
19. Conn PM, Crowley WF: Gonadotropin releasing hormone and its analogues. N Engl J Med 1991;324:93-103
20. Balasch J, Jové IC, Moreno V, Civico S, Puerto B, Vanrell JA: The comparison of two gonadotropin-releasing hormone-agonists in an in vitro fertilization program. Fertil Steril 1992;58:991-994
21. Nestor JJ, Ho TL, Tahilramani R, McRae GI, Vickery BH: Long acting LHRH agonists and antagonists. In LHRH and Its Analogues: Basic and Clinical Aspects, F Labrie, A Bélanger, A Dupont (eds). Amsterdam, Excerpta Medica, 1984, pp 24-35
22. Miro F, Sampaio MC, Tarin JJ, Pellicer A: Steroidogenesis in vitro of human granuiosa-luteal cells pretreated in vivo with two gonadotropin releasing hormone analogs employing different protocols. Gynecol Endocrinol 1992;6:77-84
23. Hull MGR, Armatage RJ, McDermott A: Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization. Fertil Steril 1994;62:997-1003
24. Edelstein MC, Brzyski RG, Jones GS, Simonetti S, Muasher SJ: Equivalency of human menopausal gonadotropin and follicle stimulating hormone stimulation after gonadotropin-releasing hormone-agonist suppression. Fertil Steril 1990;53:103-106
25. Neveu S, Hedom B, Bringer J, Chinchole J-M, Arnal F, Humeau C, et al.: Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril 1987;47:639-664